During the past decade, Cardiology Partners conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Partners" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Partners" are "Heart Failure" (2 trials), "Acute Coronary Syndromes" (1 trials), "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Cardiology Partners" in a lesser frequency.

Most popular intervention types in "Cardiology Partners" are "Drug" (4 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Placebo" (2 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Partners" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology Partners". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cardiology Partners, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Partners, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".